{
    "body": "What is the mode of action of bedaquiline?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24563587", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25203970", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25114537", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24173008", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23459487", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24259600"
    ], 
    "ideal_answer": [
        "Bedaquiline works by inhibiting bacterial adenosine triphosphate (ATP) synthase and represents the first novel class of antituberculosis agents that is used for treatment of multi drug resistant tuberculosis."
    ], 
    "type": "summary", 
    "id": "54d9071a4b1fd0d33c000007", 
    "snippets": [
        {
            "offsetInBeginSection": 122, 
            "offsetInEndSection": 289, 
            "text": "Bedaquiline works by inhibiting bacterial adenosine triphosphate (ATP) synthase and represents the first novel class of antituberculosis agents in more than 40 years. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25203970", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 734, 
            "offsetInEndSection": 974, 
            "text": "Bedaquiline has an entirely novel mechanism of action and so should be active against otherwise highly resistant organisms. It acts on the transmembrane component of adenosine triphosphate synthase and acts by preventing electron transport.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25114537", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 89, 
            "text": "Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24563587", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 159, 
            "offsetInEndSection": 472, 
            "text": " Bedaquiline is an anti-tuberculosis drug with unique mechanism of action. It selectively inhibits the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis like active, dormant, replicating, non-replicating, intracellular and extracellular.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24563587", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 779, 
            "offsetInEndSection": 927, 
            "text": "DATA SYNTHESIS: Bedaquiline possesses a unique mechanism of action that disrupts the activity of the mycobacterial adenosine triphosphate synthase. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24259600", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 626, 
            "offsetInEndSection": 764, 
            "text": "By directly inhibiting adenosine triphosphate (ATP) synthase, bedaquiline is effective against both replicating and dormant mycobacteria. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24173008", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1258, 
            "offsetInEndSection": 1396, 
            "text": "Enhanced sterilizing capacity via synergistic depletion of ATP further exhibits the promising potential of bedaquiline with pyrazinamide. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24173008", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 720, 
            "offsetInEndSection": 850, 
            "text": "Bedaquiline possesses a unique mechanism of action that disrupts the activity of the mycobacterial adenosine triphosphate synthase", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24259600", 
            "endSection": "abstract"
        }
    ]
}